大行評級|摩根大通:大幅上調微創機器人目標價至19.3港元 維持“中性”評級
摩根大通發表研究報告,指微創機器人最近兩個月大幅跑贏恆指達100%,主要受益於對人工智能(AI)及機器人概念的熱潮,以及收窄虧損的進度,目標可在明年收支平衡。公司近期盈利預告及訂單走勢提升了市場對其擴張裝置基地的信心,尤其是海外。該行將其對公司目標價由8.4港元大幅上調至19.3港元,維持“中性”評級。
報告指出,曾在上週的專家會議中討論包括自動化手術的外科手術機器人領域內AI技術的最新進展,指自動化手術的發展需要時間,仍需克服技術、倫理和法規方面的挑戰;現階段,AI主要用於輔助手術操作,例如精確導航、術中影像處理和機器人輔助技術,上述應用已經提高了手術效率和患者安全性,但仍然需要外科醫生的監控和參與。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.